Designed for convenient daily use, these fast-absorbing oral drops support appetite regulation, satiety, and healthy metabolic function without the need for injections.* GLP-1/GIP therapy works by supporting pathways involved in appetite control, digestion, insulin response, and energy balance
There was a significant drug effect (F 3,24 = 38.42
Key findings from clinical trials include: Reductions in waist circumference, an indirect marker of abdominal fat Improvements in metabolic markers associated with visceral adiposity (HbA1c, lipid profiles, liver enzymes) Decreased hepatic fat content in patients with fatty liver disease It is important to understand that GLP-1 medications do not 'burn' fat through thermogenesis or direct lipolysis
OzPep stocks both CJC-1295 with DAC and without DAC
Is it suitable for children